NEUSOFT XIKANG HOLDINGS INC. (9686) AI Stock Analysis

• Market Cap: HK$858.71M
• Dividend Yield: N/A
• Average Volume (3M): 56.12K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.40
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: HK
• Employees: 855
• Sector: Healthcare
• Sector Strength: 45
• Industry: Software - Services
• EPS (TTM): -0.11
• Shares Outstanding: 841,876,830
• 10 Day Avg. Volume: 77,200
• 30 Day Avg. Volume: 56,116
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$1.00
• Price Target Upside: 1.01% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 50 Neutral
• Price Target: HK$1.00 ▲(1.01% Upside)

The overall stock score reflects significant financial challenges, with declining revenues and losses being the most impactful factors. Technical analysis provides some positive momentum, but valuation concerns due to negative earnings and lack of dividends weigh heavily on the score.

NEUSOFT XIKANG HOLDINGS INC. Business Overview & Revenue Model

Company Description

Xikang Cloud Hospital Holdings, Inc. engages in the development of a city-specific cloud hospital platform. It operates through the following segments: Cloud Hospital Platform Services, Internet Medical Services, Health Management Services, and Smart Healthcare Products. The Cloud Hospital Platform Services segment offers technology solutions to local governments, medical institutions, and insurers. The Internet Medical Services segment includes online hospital, remote medical, smart family doctor, and internet home care services. The Health Management Services segment consists of comprehensive health management and chronic disease management services. The Smart Healthcare Products segment sells smart healthcare products to local governments, primary medical institutions, corporations, and individuals. The company was founded on May 12, 2011 and is headquartered in Shanghai, China.

How the Company Makes Money

Neusoft Xikang Holdings Inc. generates revenue through a diversified business model centered around its digital health solutions. The company earns money from the sale and licensing of its proprietary healthcare platforms and software solutions to hospitals, clinics, and other healthcare providers. Additionally, revenue is generated from the sale of medical devices and equipment. Neusoft Xikang also offers health management and consulting services, which provide recurring income streams. The company has established strategic partnerships with healthcare institutions and technology firms, further enhancing its market reach and revenue potential. Key factors contributing to its earnings include its ability to innovate in digital health and its strong presence in the rapidly growing healthcare technology market.

NEUSOFT XIKANG HOLDINGS INC. Financial Statement Overview

Summary

The company faces significant profitability and revenue challenges, impacting the income statement negatively. However, the balance sheet shows signs of stabilization with improving equity, and cash flows are turning positive, suggesting potential recovery if trends continue.

Income Statement

The company demonstrates a consistent decline in revenue from 2022 to 2024, with a significant decrease in net income, resulting in negative net profit margins. Both EBIT and EBITDA margins are also negative, reflecting ongoing operational challenges and profitability issues.

Balance Sheet

The balance sheet shows improvement with a positive stockholders' equity in 2023 and 2024, although the company still has a high debt-to-equity ratio due to substantial liabilities. The equity ratio remains low, indicating a potential risk in financial stability despite improved equity.

Cash Flow

Cash flow improved in 2024 with positive operating and free cash flows, reversing previous negative trends. The operating cash flow to net income ratio reflects a better alignment between cash flow generation and accounting income, yet the free cash flow growth is volatile.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	501.50M	537.72M	687.41M	614.30M	503.01M
Gross Profit	147.50M	164.61M	168.45M	170.23M	134.11M
EBITDA	-52.06M	-75.65M	-161.41M	-214.71M	-101.65M
Net Income	-83.05M	-154.65M	-241.97M	-296.54M	-196.43M
Balance Sheet
Total Assets	1.26B	1.40B	934.45M	946.85M	954.64M
Cash, Cash Equivalents and Short-Term Investments	797.70M	856.13M	351.76M	364.91M	419.87M
Total Debt	574.47M	603.44M	573.44M	456.28M	446.23M
Total Liabilities	892.31M	964.28M	1.38B	1.21B	1.09B
Stockholders Equity	363.31M	428.14M	-451.98M	-274.55M	-132.99M
Cash Flow
Free Cash Flow	21.56M	-24.42M	-81.17M	-101.77M	-124.13M
Operating Cash Flow	21.56M	-20.16M	-73.83M	-83.38M	-17.30M
Investing Cash Flow	110.45M	-146.60M	-8.45M	-5.47M	-195.16M
Financing Cash Flow	-56.56M	504.77M	64.62M	64.90M	216.29M

NEUSOFT XIKANG HOLDINGS INC. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.99
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9686, the sentiment is Positive. The current price of 0.99 is above the 20-day moving average (MA) of 0.98, above the 50-day MA of 0.97, and above the 200-day MA of 0.89, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.55 is Neutral, neither overbought nor oversold. The STOCH value of 81.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:9686.

NEUSOFT XIKANG HOLDINGS INC. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2276	67 Neutral	20.62B	35.68	27.01%	0.82%	13.58%	24.59%
2251	53 Neutral	1.51B	-7.83	-20.13%	―	-32.17%	-1.20%
2160	51 Neutral	3.14B	581.82	-2.26%	―	-4.38%	―
9686	50 Neutral	HK$858.71M	―	-20.43%	―	―	―
2170	47 Neutral	826.05M	-3.24	-20.74%	―	11.43%	4.88%
2158	42 Neutral	5.42B	-48.63	-3.00%	―	-12.31%	41.72%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

NEUSOFT XIKANG HOLDINGS INC. Corporate Events

Xikang Cloud Hospital Holdings Reports Improved Losses Amid Revenue Dip

Xikang Cloud Hospital Holdings Inc. announced its interim results for the first half of 2025, reporting a slight revenue decrease of 0.3% compared to the same period in 2024, with a total revenue of RMB178.6 million. Despite the revenue dip, the company reduced its net loss by 17.4% to RMB50.0 million, attributed to business optimization and resource allocation improvements. The company’s unique business model, which involves strategic collaboration with local governments, aims to enhance the regional digital healthcare ecosystem through AI-driven innovations and scalable cloud hospital platforms.

The most recent analyst rating on (HK:9686) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on NEUSOFT XIKANG HOLDINGS INC. stock, see the HK:9686 Stock Forecast page.

Xikang Cloud Hospital Holdings to Discuss Interim Results and Dividend

Xikang Cloud Hospital Holdings Inc. has announced a board meeting scheduled for August 27, 2025, to discuss and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the recommendation of an interim dividend, indicating a potential financial distribution to shareholders, which could impact investor sentiment and the company’s market positioning.

Xikang Cloud Hospital Grants Share Options to Boost Stakeholder Alignment

Xikang Cloud Hospital Holdings Inc. announced the grant of 28,990,000 share options to 236 eligible participants under its Post-IPO Share Option Scheme. The options, which have an exercise price of HK$0.904 per share, are subject to a vesting schedule over three years and performance targets based on financial and business-related indicators. The scheme includes a clawback mechanism for violations of laws or company rules, ensuring alignment with company goals and stakeholder interests.